Underneath the impressive market rally is a trend that doesn't seem quite right, according to J.P. Morgan.Marketsread more
Tesla is working on new battery cell designs, and a way to make their own cells, with R&D teams in a lab near its car plant in Fremont, California.Technologyread more
The Federal Reserve and the market are miles apart on interest rate expectations, and the disparity could cost the stock market a 7%-10% drop, economists say.Economyread more
Something unusual is happening in financial markets and it could mean more gains lie ahead for stocks, if history is any indication.Marketsread more
JP Morgan's Jamie Dimon says student lending "is a disgrace and it's hurting America."Economyread more
Online home goods retailer Wayfair sold roughly 1,600 mattresses and 100 bunk beds to Baptist Child and Family Services, a nonprofit that works as a federal contractor...Retailread more
The Senate will try to reconcile its emergency border aid plan with one passed by Nancy Pelosi and House Democrats.Politicsread more
During the foreclosure crisis, investors transformed the single-family home rental market into a formally managed asset class. Now they want new homes.Real Estateread more
Bitcoin topped the $13,000 level Wednesday, rallying to its highest price since January 2018.Bitcoinread more
Lenders including J.P. Morgan Chase and Bank of America are widely expected to increase dividends this week.Financeread more
The president raised $6 million alone at a fundraiser he attended at the Trump International Hotel on Tuesday in Washington.Politicsread more
President Donald Trump called for legislation that would lower the prices of pharmaceutical drugs in the U.S. in his State of the Union address on Tuesday night.
"It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place," Trump said. "This is wrong, unfair, and together we will stop it."
"I am asking Congress to pass legislation that finally takes on the problem of global freeloading and delivers fairness and price transparency for American patients," Trump added. "We should also require drug companies, insurance companies, and hospitals to disclose real prices to foster competition and bring costs way down."
Trump's remarks on drug pricing come after the administration proposed a ban on so-called backdoor deals cut by pharmaceutical companies with middlemen who get preferred status for their drugs through Medicare.
Right now, drug companies pay rebates to pharmacy benefit management (PBM) companies like CVS Health to include their medications on Medicare Part D plans. The Trump administration's proposal would leave PBMs receiving just a flat fee for including drugs on those plans. It would also pass approximately $29 billion in drug-company rebates to consumers.
Wall Street strategists said ahead of the speech that Trump's comments on drug pricing, along with infrastructure and trade, could be market moving. Strategists warned major drug stocks like Merck and Pfizer, as well as related companies like CVS Health and UnitedHealth, could come under pressure if Trump came out strong against high drug prices.
The speech comes more than a week after the longest government shutdown in U.S. history ended. On Jan. 25, both Trump and Democratic leaders in Congress agreed to re-open the government for three weeks.
This is breaking news. Please check back for updates.